EnteroBiotix Company
Microbiome modulating drugs, preventative treatment. Mission is to harness the therapeutic potential of diverse and intact donor-derived microbial communities to redefine the way we treat disease and improve health and wellbeing.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2017
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
4
Total Funding:
£2.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Seed
Register and Claim Ownership